IQVIA Holdings Inc (IQV) Stock Analysis

IQVIA Holdings Inc (IQV) is a publicly traded company in the HEALTHCARE sector. It trades at $180.60, carries a market capitalization of $31.18B, a price-to-earnings ratio of 23.21. This page summarizes the public market data, fundamentals, and frequently asked questions for IQV, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NYSE

Key Metrics

Market Sentiment

IQVIA Holdings Inc currently has a Bullish sentiment score of 0.22.

About IQVIA Holdings Inc

IQVIA Holdings Inc. is a premier global provider of advanced analytics, technology solutions, and contract research services, primarily catering to the healthcare sector. Formed through the merger of Quintiles and IMS Health, IQVIA excels in biopharmaceutical development and commercial outsourcing, offering comprehensive support for Phase I-IV clinical trials and laboratory services. By harnessing state-of-the-art data and technology, the company is committed to driving innovation, enhancing ...

GNG Research Analysis

GNG Research scores IQVIA Holdings Inc (IQV) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for IQV.

Frequently Asked Questions

Does IQV pay dividends?

IQVIA Holdings Inc (IQV) does not currently pay a regular dividend.

What is IQV's P/E ratio?

IQVIA Holdings Inc has a price-to-earnings (P/E) ratio of 23.21.

What is IQV's market cap?

IQVIA Holdings Inc (IQV) has a market capitalization of $31.18B with a current stock price of $180.60.